L vs RNAZ · P/E 14, rev $18.45B vs $5.1M cap
Loews Corp (L) versus Transcode Therapeutics Inc (RNAZ) — a side-by-side from cached financials, not a winner call.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Transcode Therapeutics Inc (RNAZ) is a biotechnology company listed on NASDAQ.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
RNAZ does not have a complete income-statement cache yet.
L currently screens at market cap $22.36B and trailing P/E 13.8. RNAZ currently screens at market cap $5.1M.
Not investment advice. Open the L and RNAZ stock pages for the full models.
Not investment advice.